Purchase Order 75N95025P00307

Award Date 7/1/25
Potential Completion Date 7/31/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract has a ceiling value of $107,615.73 and a completion date of May 10, 2018. The Johns Hopkins University, a private research university located in Baltimore, Maryland, is the prime contractor for this award. This contract does not have a set-aside designation. Based on the...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,007.40 firm fixed price purchase order contract to The Johns Hopkins University, a private non-profit university located in Baltimore, Maryland. The contract has no set-aside designation and was awarded on September 7, 2018 with a completion date of January 10, 2020. As a leading research institution, The Johns Hopkins University has a history of providing the U.S. government...
This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract has a ceiling value of $109,658.00 and is a definitive, cost-no-fee contract with a period of performance ending on June 30, 2017. The contract does not have a set-aside designation. The Johns Hopkins University, a private research university located in Baltimore, Maryland, is the prime contractor for...
This is a $114,800 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University, a private research university in Baltimore, MD. The contract has an ultimate completion date of September 29, 2016 and was awarded on September 28, 2015. This contract was not set aside for any specific business type. The Johns Hopkins University has a strong track record of providing research,...
This is a $126,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to The Johns Hopkins University in Baltimore, Maryland. The contract is for JHMI DEEP SEQUENCING AND MICROARRAY CORE services and has an ultimate completion date of December 31, 2017. The award was made on September 23, 2016 and does not utilize a set-aside. The Johns Hopkins University is a private...
This federal contract award, valued at $149,999.58, was issued by the U.S. Department of Health and Human Services (HHS) to the Johns Hopkins Health System Corporation (doing business as Johns Hopkins Medicine), a non-profit healthcare organization based in Baltimore, Maryland. The contract is for training services to the National Institutes of Health (NIH) Office of the Director (OD) on biomedical data science. The contract has a firm-fixed-price structure and does not have a set-aside...
The National Institutes of Health's National Institute on Drug Abuse awarded a $32,720 purchase order to The Johns Hopkins University for gene sequencing and profiling of sample tissue. This firm fixed price contract supports the NIH/NIDA's biomedical research efforts through Johns Hopkins' delivery of genomic analysis services. No subcontractors or set aside designations were identified. The one year period of performance begins in July 2023, with work conducted at Johns Hopkins' Bethesda,...
The federal contract HHSN271201400042C, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Johns Hopkins Bayview Medical Center, Inc. (Johns Hopkins Bayview) is for the provision of CLINICAL SUPPORT SERVICES AND RESOURCES. This is a Cost Plus Fixed Fee definitive contract with a potential value of $5,027,325.87 and a period of performance from July 29, 2014 to June 30, 2019. The contract was not set aside for any...
The U.S. Department of Health and Human Services (HHS) awarded a $18,000 firm fixed-price purchase order contract to The Johns Hopkins University, a private, non-profit research university located in Baltimore, Maryland. The contract, which does not have a set-aside designation, has an ultimate completion date of August 1, 2012. The contract supports the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), in its mission to...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency, to The Johns Hopkins University for a value of $20,000.00. The contract is for animal studies to examine the effect of fatty acid amide hydrolase inhibitors on neuropathic pain, to be performed by researchers from Johns Hopkins. This work does not have a set-aside designation. The Johns Hopkins University is a private research university that has extensive...

This is a $14,616 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to The Johns Hopkins Health System Corporation (Johns Hopkins Medicine), a non-profit healthcare organization based in Baltimore, Maryland. The contract does not have a set-aside designation. Johns Hopkins Medicine has been awarded various federal contracts and grants from HHS agencies, including the National Institutes of Health (NIH), to provide medical services, consultations, laboratory testing, and research support. This specific purchase order is for an unspecified purpose with a period of performance ending on July 31, 2025.

Generated 7/1/25, 9:23 AM